66 related articles for article (PubMed ID: 10410307)
1. Hydrogen peroxide mediates doxorubicin-induced transglutaminase 2 expression in PC-14 human lung cancer cell line.
Han JA; Park SC
Exp Mol Med; 1999 Jun; 31(2):83-8. PubMed ID: 10410307
[TBL] [Abstract][Full Text] [Related]
2. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line.
Han JA; Park SC
J Cancer Res Clin Oncol; 1999; 125(2):89-95. PubMed ID: 10190315
[TBL] [Abstract][Full Text] [Related]
3. Differential oxygen radical susceptibility of adriamycin-sensitive and -resistant MCF-7 human breast tumor cells.
Mimnaugh EG; Dusre L; Atwell J; Myers CE
Cancer Res; 1989 Jan; 49(1):8-15. PubMed ID: 2535695
[TBL] [Abstract][Full Text] [Related]
4. Importance of Ca(2+)-dependent transamidation activity in the protection afforded by tissue transglutaminase against doxorubicin-induced apoptosis.
Datta S; Antonyak MA; Cerione RA
Biochemistry; 2006 Nov; 45(44):13163-74. PubMed ID: 17073438
[TBL] [Abstract][Full Text] [Related]
5. Xanthine oxidase-generated hydrogen peroxide is a consequence, not a mediator of cell death.
Czupryna J; Tsourkas A
FEBS J; 2012 Mar; 279(5):844-55. PubMed ID: 22230240
[TBL] [Abstract][Full Text] [Related]
6. Expression and activity of transglutaminase II in spontaneous tumours of dogs and cats.
Wakshlag JJ; McNeill CJ; Antonyak MA; Boehm JE; Fuji R; Balkman CE; Zgola M; Cerione RA; Page RL
J Comp Pathol; 2006; 134(2-3):202-10. PubMed ID: 16615935
[TBL] [Abstract][Full Text] [Related]
7. In vivo transglutaminase type 1 expression in normal lung, preinvasive bronchial lesions, and lung cancer.
Martinet N; Bonnard L; Regnault V; Picard E; Burke L; Siat J; Grosdidier G; Martinet Y; Vignaud JM
Am J Respir Cell Mol Biol; 2003 Apr; 28(4):428-35. PubMed ID: 12654631
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin increases intracellular hydrogen peroxide in PC3 prostate cancer cells.
Wagner BA; Evig CB; Reszka KJ; Buettner GR; Burns CP
Arch Biochem Biophys; 2005 Aug; 440(2):181-90. PubMed ID: 16054588
[TBL] [Abstract][Full Text] [Related]
9. Sub-toxic cisplatin mediates anoikis resistance through hydrogen peroxide-induced caveolin-1 up-regulation in non-small cell lung cancer cells.
Songserm T; Pongrakhananon V; Chanvorachote P
Anticancer Res; 2012 May; 32(5):1659-69. PubMed ID: 22593444
[TBL] [Abstract][Full Text] [Related]
10. Depletion of nucleophosmin via transglutaminase 2 cross-linking increases drug resistance in cancer cells.
Park KS; Han BG; Lee KH; Kim DS; Kim JM; Jeon H; Kim HS; Suh SW; Lee EH; Kim SY; Lee BI
Cancer Lett; 2009 Feb; 274(2):201-7. PubMed ID: 18851895
[TBL] [Abstract][Full Text] [Related]
11. Expression of the prostate transglutaminase (TGase-4) in prostate cancer cells and its impact on the invasiveness of prostate cancer.
Davies G; Ablin RJ; Mason MD; Jiang WG
J Exp Ther Oncol; 2007; 6(3):257-64. PubMed ID: 17552366
[TBL] [Abstract][Full Text] [Related]
12. C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line.
Nishanth RP; Ramakrishna BS; Jyotsna RG; Roy KR; Reddy GV; Reddy PK; Reddanna P
Eur J Pharmacol; 2010 Dec; 649(1-3):74-83. PubMed ID: 20858479
[TBL] [Abstract][Full Text] [Related]
13. Peroxide is a key mediator of Bcl-2 down-regulation and apoptosis induction by cisplatin in human lung cancer cells.
Wang L; Chanvorachote P; Toledo D; Stehlik C; Mercer RR; Castranova V; Rojanasakul Y
Mol Pharmacol; 2008 Jan; 73(1):119-27. PubMed ID: 17911532
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo.
Alexandre J; Batteux F; Nicco C; Chéreau C; Laurent A; Guillevin L; Weill B; Goldwasser F
Int J Cancer; 2006 Jul; 119(1):41-8. PubMed ID: 16450384
[TBL] [Abstract][Full Text] [Related]
15. High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells.
Mehta K
Int J Cancer; 1994 Aug; 58(3):400-6. PubMed ID: 7914183
[TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue and epidermal transglutaminases in mouse epidermal cells after treatment with 12-O-tetradecanoylphorbol-13-acetate and/or retinoic acid in vivo and in culture.
Lichti U; Yuspa SH
Cancer Res; 1988 Jan; 48(1):74-81. PubMed ID: 2891434
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of tissue transglutaminase expression and activation by epidermal growth factor inhibit doxorubicin-induced apoptosis in human breast cancer cells.
Antonyak MA; Miller AM; Jansen JM; Boehm JE; Balkman CE; Wakshlag JJ; Page RL; Cerione RA
J Biol Chem; 2004 Oct; 279(40):41461-7. PubMed ID: 15272014
[TBL] [Abstract][Full Text] [Related]
18. Induction of CD95 ligand and apoptosis by doxorubicin is modulated by the redox state in chemosensitive- and drug-resistant tumor cells.
Friesen C; Fulda S; Debatin KM
Cell Death Differ; 1999 May; 6(5):471-80. PubMed ID: 10381639
[TBL] [Abstract][Full Text] [Related]
19. The role of reactive oxygen species in WP 631-induced death of human ovarian cancer cells: a comparison with the effect of doxorubicin.
Rogalska A; Gajek A; Szwed M; Jóźwiak Z; Marczak A
Toxicol In Vitro; 2011 Dec; 25(8):1712-20. PubMed ID: 21896327
[TBL] [Abstract][Full Text] [Related]
20. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin.
Liebmann J; Fisher J; Lipschultz C; Kuno R; Kaufman DC
Cancer Res; 1995 Oct; 55(19):4465-70. PubMed ID: 7671261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
